Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check6 days agoChange DetectedOn 2026-05-27, the history adds the Study Status and Contacts/Locations sections (version 241) to the record, indicating updated status details and contact information for the trial. A deletion from 2026-05-22 is also reflected in the history.SummaryDifference0.1%

- Check13 days agoChange DetectedThe record history gains entries for Contacts/Locations and Study Status, with corresponding updates on 2026-05-19 to 2026-05-22, indicating where the trial is conducted and the latest status visible in the history.SummaryDifference0.2%

- Check20 days agoChange DetectedNew history entries for May 9–15, 2026 add Contacts/Locations, Study Status, and Arms and Interventions sections, along with a new Revision: v3.5.4. This update appears to supersede the prior Revision: v3.5.3.SummaryDifference0.3%

- Check27 days agoChange DetectedAdded entries for Contacts/Locations and Study Status in the study record history, indicating updates to those sections within the version history.SummaryDifference0.2%

- Check34 days agoChange DetectedA new version entry dated 2026-05-01 adds Contacts/Locations and Study Status to the study record history. It also references a 2026-04-30 addition and a deletion on 2026-04-24.SummaryDifference0.1%

- Check42 days agoChange DetectedThe record history page reflects routine updates to the displayed version list and site/view revision information (moving from one revision/version label to the next). It also includes new/removed entries around recent submission dates for contacts and study status in the history log.SummaryDifference0.2%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.